ALFREDO RAMIREZ: Open Payments
NPI 1043851033 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 36 payments from 10 companies in 2025. Trend: 2023 $2,979 · 2024 $1,257 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 15 | $283 |
| E.R. Squibb & Sons, L.L.C. | 8 | $243 |
| Neurocrine BioSciences, Inc. | 5 | $108 |
| Axsome Therapeutics, Inc. | 1 | $91 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
Products named: SPRAVATO, COBENFY, INGREZZA, Auvelity, REXULTI, FANAPT, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
